NUTX vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

NUTX

56.7
AI Score
VS
NUTX Wins

MD

35.0
AI Score

Investment Advisor Scores

NUTX

57score
Recommendation
HOLD

MD

35score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NUTX MD Winner
Net Income 70.79M 69.42M NUTX
Operating Income 275.63M 98.58M NUTX
ROE 21.5% 7.9% NUTX
ROA 7.7% 3.3% NUTX
Total Assets 918.52M 2.13B MD
Cash 185.57M 288.88M MD
Debt/Equity 0.09 0.69 NUTX
Current Ratio 3.41 1.32 NUTX

Relative Price Performance (Last 90 Days)

NUTX 1M: +2.1% · 3M: +41.3% MD 1M: +14.3% · 3M: +12.5%

Current Technical Phase

NUTX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.7% over 20 days), RSI 52

RSI (14): 52.3 · Price: $206.09

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 75

RSI (14): 74.7 · Price: $29.55

Fundamentals Snapshot

Metric NUTX MD
Market Cap — —
Forward P/E 7.4 12.1
Trailing P/E 7.8 13.4
Revenue (TTM) — —
Revenue Growth -0.1% 0.0%
Gross Margin 0.5% 0.3%
Operating Margin 0.6% 0.1%
EPS 25.24 2.09
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NUTX is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.